Dysfunctional uterine bleeding surgery: Difference between revisions

Jump to navigation Jump to search
m (Bot: Removing from Primary care)
 
(4 intermediate revisions by the same user not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Dysfunctional uterine bleeding}}
{{Dysfunctional uterine bleeding}}
{{CMG}} {{AE}} {{VVS}}
{{CMG}}; {{AE}} [[User:AroojNaz|Arooj Naz, M.B.B.S]], {{VVS}}
== Surgery ==  
 
* Hysterectomy
==Overview==
* Endometrial ablation
Surgical procedures are reserved for patients that are unresponsive to medical treatment or those that do not desire [[fertility]]. Procedures can be specific according to underlying causes of dysfunctional bleeding as well as cancer stage. Common surgical interventions include [[hysterectomy]], [[endometrial ablation]] and [[laparoscopic removal]]. 
=== Indications for Surgery ===  
 
* Anatomic causes
==Surgery==
* If fertility is not desired
 
 
As surgery is more invasive, it is often reserved for cases uncontrolled by medications or those not desiring [[fertility]].<ref name="pmid15117012">{{cite journal| author=Albers JR, Hull SK, Wesley RM| title=Abnormal uterine bleeding. | journal=Am Fam Physician | year= 2004 | volume= 69 | issue= 8 | pages= 1915-26 | pmid=15117012 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15117012  }}</ref> Underlying anatomical cases of [[DUB]] are also an indication for surgery. Surgical treatments can be tailored according to the underlying cause of bleeding.
{| class="wikitable"
|+Surgical Options
!Condiiton
!Surgical Treatment<ref name="pmid304225082">{{cite journal| author=| title=StatPearls | journal= | year= 2022 | volume=  | issue=  | pages=  | pmid=30422508 | doi= | pmc= | url= }}</ref>
|-
|[[Endometrial Polyps|Polyps]]
|
*Surgical resection of polyps ([[polypectomy]])
*Polyps larger than 1.5 cm are unlikely to respond spontaneously and should consider [[polypectomy]]<ref name="pmid30855861">{{cite journal| author=| title=StatPearls | journal= | year= 2022 | volume=  | issue=  | pages=  | pmid=30855861 | doi= | pmc= | url= }}</ref>
*[[Dilation and curettage (patient information)|Dilation and curettage]]<ref name="pmid31105939">{{cite journal| author=Nijkang NP, Anderson L, Markham R, Manconi F| title=Endometrial polyps: Pathogenesis, sequelae and treatment. | journal=SAGE Open Med | year= 2019 | volume= 7 | issue=  | pages= 2050312119848247 | pmid=31105939 | doi=10.1177/2050312119848247 | pmc=6501471 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=31105939  }}</ref>
|-
|[[Adenomyosis]]
|
*[[Hysterectomy]]
*[[Adenomyomectomy]]
*[[Endometrial ablation]]
*[[Uterine artery ligation]] or [[Uterine artery embolization|embolization]]<ref name="pmid24771944">{{cite journal| author=Taran FA, Stewart EA, Brucker S| title=Adenomyosis: Epidemiology, Risk Factors, Clinical Phenotype and Surgical and Interventional Alternatives to Hysterectomy. | journal=Geburtshilfe Frauenheilkd | year= 2013 | volume= 73 | issue= 9 | pages= 924-931 | pmid=24771944 | doi=10.1055/s-0033-1350840 | pmc=3859152 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24771944  }}</ref>
|-
|[[Leiomyoma]] (fibroids)
|
*[[Hysterectomy]] (definitive treatment)<ref name="pmid308558612">{{cite journal| author=| title=StatPearls | journal= | year= 2022 | volume=  | issue=  | pages=  | pmid=30855861 | doi= | pmc= | url= }}</ref>
 
*[[Uterine artery embolization]]
*[[Endometrial ablation]]
|-
|[[Uterine cancer|Malignancy]] <ref name="pmid32965984">{{cite journal| author=| title=StatPearls | journal= | year= 2022 | volume=  | issue=  | pages=  | pmid=32965984 | doi= | pmc= | url= }}</ref>
|
*[[Surgical resection]] +/- [[adjuvant treatment]]
 
{| class="wikitable"
|+Surgical Treatment based on Cancer Stage
!Stage
!Treatment
|-
|1
|[[Transabdominal hysterectomy with bilateral salpingo-oophorectomy]]
|-
|2
|Radical or simple [[hysterectomy]] along with adjuvant [[radiotherapy]]
|-
|3
|[[Transabdominal hysterectomy with bilateral salpingo-oophorectomy]] and pelvic radiation
|-
|4
|Surgical resection and [[radiation]] therapy
|-
|5
|[[Palliative care]]; focus is on improving quality of life
|}
|-
|[[PCOS]]
|
*[[Laparoscopic surgery]]; [[ovarian drilling]]
|-
|[[Endometriosis]]
|
*[[Hysterectomy]]
*[[Endometrial ablation]]
|}


==References==
==References==

Latest revision as of 01:26, 7 August 2022

Dysfunctional uterine bleeding Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Dysfunctional uterine bleeding from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Dysfunctional uterine bleeding surgery On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Dysfunctional uterine bleeding surgery

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Dysfunctional uterine bleeding surgery

CDC on Dysfunctional uterine bleeding surgery

Dysfunctional uterine bleeding surgery in the news

Blogs on Dysfunctional uterine bleeding surgery

Directions to Hospitals Treating Dysfunctional uterine bleeding

Risk calculators and risk factors for Dysfunctional uterine bleeding surgery

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Arooj Naz, M.B.B.S, Vishnu Vardhan Serla M.B.B.S. [2]

Overview

Surgical procedures are reserved for patients that are unresponsive to medical treatment or those that do not desire fertility. Procedures can be specific according to underlying causes of dysfunctional bleeding as well as cancer stage. Common surgical interventions include hysterectomy, endometrial ablation and laparoscopic removal.

Surgery

As surgery is more invasive, it is often reserved for cases uncontrolled by medications or those not desiring fertility.[1] Underlying anatomical cases of DUB are also an indication for surgery. Surgical treatments can be tailored according to the underlying cause of bleeding.

Surgical Options
Condiiton Surgical Treatment[2]
Polyps
Adenomyosis
Leiomyoma (fibroids)
Malignancy [7]
Surgical Treatment based on Cancer Stage
Stage Treatment
1 Transabdominal hysterectomy with bilateral salpingo-oophorectomy
2 Radical or simple hysterectomy along with adjuvant radiotherapy
3 Transabdominal hysterectomy with bilateral salpingo-oophorectomy and pelvic radiation
4 Surgical resection and radiation therapy
5 Palliative care; focus is on improving quality of life
PCOS
Endometriosis

References

  1. Albers JR, Hull SK, Wesley RM (2004). "Abnormal uterine bleeding". Am Fam Physician. 69 (8): 1915–26. PMID 15117012.
  2. "StatPearls".   ( ). 2022:  . PMID 30422508.
  3. "StatPearls".   ( ). 2022:  . PMID 30855861.
  4. Nijkang NP, Anderson L, Markham R, Manconi F (2019). "Endometrial polyps: Pathogenesis, sequelae and treatment". SAGE Open Med. 7 ( ): 2050312119848247. doi:10.1177/2050312119848247. PMC 6501471 Check |pmc= value (help). PMID 31105939.
  5. Taran FA, Stewart EA, Brucker S (2013). "Adenomyosis: Epidemiology, Risk Factors, Clinical Phenotype and Surgical and Interventional Alternatives to Hysterectomy". Geburtshilfe Frauenheilkd. 73 (9): 924–931. doi:10.1055/s-0033-1350840. PMC 3859152. PMID 24771944.
  6. "StatPearls".   ( ). 2022:  . PMID 30855861.
  7. "StatPearls".   ( ). 2022:  . PMID 32965984 Check |pmid= value (help).

Template:WH Template:WS